Page 12 - Zai Lab Forward News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zai Lab Partner argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia

Zai Lab Partner argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesHong kongAlina zhangDanielle halstrom xiaoyu chenExchange commissionInternational working groupZai labZai lab limitedZai lab forwardLab limitedWorking groupGreater chinaNorth americaImmune thrombocytopeniaPrivate securities litigation reform act

Zai Lab Presents Positive Results from Phase 3 PRIME Study

PRIME study demonstrates that niraparib treatment had a statistically significant and clinically meaningful improvement in progression-free survival in the.

United kingdomHong kongAlan sandlerRon aldridgeAlina zhangLingying wuDanielle halstrom xiaoyu chenZai labZai lab limitedZai laboratoryChina national medical products administrationNational healthcare security administrationZai lab forwardSociety of gynecologic oncologyNational cancer center clinical researchUnion medical college

Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United kingdomHong kongAlan sandlerRon aldridgeAlina zhangLingying wuDanielle halstrom xiaoyu chenZai labZai lab limitedZai laboratoryChina national medical products administrationNational healthcare security administrationZai lab forwardSociety of gynecologic oncologyNational cancer center clinical researchUnion medical college

Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomJosh smileyRon aldridgeAlina zhangEli lillyDanielle halstrom xiaoyu chenGlobal business servicesZai labZai lab limitedExchange commissionCo lillyHarvard collegeZai lab forwardBoard of zai labLab limited

Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., March 15, 2022 Zai Lab Limited , a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced the. | March 15, 2022

United statesUnited kingdomJosh smileyRon aldridgeAlina zhangEli lillyDanielle halstrom xiaoyu chenGlobal business servicesZai labZai lab limitedExchange commissionCo lillyHarvard collegeZai lab forwardBoard of zai labLab limited